...

PsychedelicNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Supports Executive Order Advancing Psychedelic Therapies

Today 11:41 EDT

Via Investor Brand Network

Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soar ↗

Today 11:27 EDT

Via The Motley Fool

BioMedNewsBreaks — Lantern Pharma (NASDAQ: LTRN) Schedules FDA Type C Meeting For HARMONIC Trial Amendments

Today 10:38 EDT

Via Investor Brand Network

BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Supports Executive Order To Accelerate Psychedelic Drug Development

Today 10:20 EDT

Via Investor Brand Network

PharmaTher's Microneedle Patch Platforms Positioned to Benefit from Major U.S. Catalysts in Psychedelics and Peptides

Today 8:00 EDT

Via Newsfile

Baby Food Recalled After Jars Test Positive For Rat Poison ↗

Today 3:54 EDT

Via Benzinga

AMATORUS WOUND GUARD Passes all Antimicrobial Efficacy Testing

April 19, 2026

Via Press Release Distribution Service

Compass Pathways Cheers Trump Order To Accelerate Access To Psychedlic Drug Treatements: 'Recognizes Profound Urgency Of Mental Health Crisis' ↗

April 19, 2026

Via Benzinga

IMMUNITYBIO DEADLINE FOR LEADERSHIP is May 26, 2026 in a Securities Fraud Lawsuit - Investors Encouraged to Contact Kaplan Fox

April 18, 2026

Via NewMediaWire

IMMUNITYBIO DEADLINE FOR LEADERSHIP is May 26, 2026 in a Securities Fraud Lawsuit - Investors Encouraged to Contact Kaplan Fox

April 18, 2026

Via TheNewswire.com

3 Catalysts That Could Send Teva Stock to $40 and Beyond ↗

April 18, 2026

Via The Motley Fool

autoTECH Blackhawk Provides Reliable, Full-Service Car Maintenance in Danville

April 17, 2026

Via GetFeatured

The Psychedelic Revolution in Mental Healthcare ↗

April 17, 2026

Via The Motley Fool

Lifelike Tattoo Studio: Where Ink Becomes Identity in Houston

April 17, 2026

Via AB Newswire

Bread Loaf’s CEO Mark Milutin Breaks Down FDA Peptide Shift and What It Means for Telehealth

April 17, 2026

Via AB Newswire

Goldman Sachs' 2 Favorite Under-the-Radar Stocks ↗

April 17, 2026

Via Benzinga

OEM Water Bottle Manufacturing Guide: A Complete Handbook for Brand Owners & Buyers

April 17, 2026

Via AB Newswire

Deadline to Lead in Securities Class Action Against ImmunityBio, Inc. (NASDAQ: IBRX) is May 26, 2026 - Contact Kaplan Fox

April 17, 2026

Via TheNewswire.com

Deadline to Lead in Securities Class Action Against ImmunityBio, Inc. (NASDAQ: IBRX) is May 26, 2026 - Contact Kaplan Fox

April 17, 2026

Via NewMediaWire

AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Closes $10 Million Public Offering to Advance Cardiac Technology Commercialization

April 17, 2026

Via Investor Brand Network

$9.1 Billion Mesenchymal Stem Cell Market by 2031 to be Focused on by New Senior Scientific Advisor for KALA BIO, Inc. (Nasdaq: KALA)

April 17, 2026

Via Get News

3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist ↗

April 16, 2026

Via The Motley Fool

Stock Market Today, April 16: Hims & Hers Health Jumps on FDA Review of Compounded Peptide Therapies ↗

April 16, 2026

Via The Motley Fool

RFK Jr. Just Gave Hims & Hers Stock a Jolt. Should You Chase the Rally Here?

April 16, 2026

Via Barchart.com

IMMUNITYBIO DEADLINE: Investors of ImmunityBio, Inc. (NASDAQ: IBRX) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 26, 2026

April 16, 2026

Via NewMediaWire

IMMUNITYBIO DEADLINE: Investors of ImmunityBio, Inc. (NASDAQ: IBRX) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 26, 2026

April 16, 2026

Via TheNewswire.com

Hims & Hers Spikes; Will The FDA Blow The Door Open On Peptide Compounding? ↗

April 16, 2026

Via Investor's Business Daily

Eli Lilly's New Oral Weight Loss Drug Clears Cardiovascular Bar ↗

April 16, 2026

Via Benzinga

FDA To Review Easing Grip On Several Peptide Therapies Popular Among Influencers And Fitness Gurus In Potential Win For RFK Jr. ↗

April 16, 2026

Via Benzinga

PharmaTher Supports Proposed U.S. Peptide Reclassification, Reinforcing the Strategic Value of Its Microneedle Patch Platforms for Peptide Delivery

April 16, 2026

Via Newsfile

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.